Feb 19, 2013 at 22:31 | Source: PTI
Feb 15, 2013 at 15:43 | Source: Moneycontrol.com
Oct 17, 2012 at 15:00 | Source: PTI
Oct 17, 2012 at 14:51 | Source: PTI
Sep 28, 2012 at 15:07 | Source: Moneycontrol.com
Karvy Stock Broking has come out with its report on pharma pricing policy. The research firm initial assessment is based on a 50 % price cut and a possible 80% price cut for products marked in Light Blue. The impact based on the above methodology shows a higher impact on Sanofi Aventis, GSK Pharma, Cipla, Ranbaxy Labs.
Aug 16, 2012 at 14:00 | Source: Moneycontrol.com
News across the web »
New Delhi, May 24: The Centre has filed a special leave petition (SLP) before the Supreme Court against the Andhra Pradesh High Court ruling in the Sanofi case. The AP High Court had in February rule...
May 25, 2013 at 00:22 | Source: The Hindu BusinessLine
New Delhi, May 19: With no let up in multinationals seeking nod to acquire stake in Indian pharma firms despite government putting norms to check it, DIPP has raised concerns stating the FDI policy i...
May 19, 2013 at 14:52 | Source: The Hindu BusinessLine
New Delhi, May 13: Unhappy with the “mass approval” given by the Foreign Investment Promotion Board (FIPB) for foreign investments in existing Indian pharmaceutical companies, the Departm...
May 13, 2013 at 22:21 | Source: The Hindu BusinessLine
NEW DELHI: Foreign direct investment in the pharmaceutical sector faces fresh headwinds with the department of industrial policy and promotion (DIPP) seeking a review of the policy barely months afte...
May 13, 2013 at 05:40 | Source: Economic Times
Investors, buffeted by the wild swings in stock markets in the last five years, have sought refuge in stocks of ‘defensive’ pharma companies. After all, drug sales aren’t particular...
Apr 27, 2013 at 23:46 | Source: The Hindu BusinessLine
Interact & exchange stock tips & market info »
1.16 PM Oct 18th 2012
1.13 PM Oct 18th 2012
5.18 PM Oct 17th 2012